Cargando…

The use of amisulpride in schizophrenic patients with resistant symptomatology

Detalles Bibliográficos
Autores principales: Kalfas, Dimitrios, Markou, Sophia, Gkletsos, Apostolos, Parga, Maria, Karras, Theodoros
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991820/
http://dx.doi.org/10.1186/1744-859X-9-S1-S135
_version_ 1782192643769368576
author Kalfas, Dimitrios
Markou, Sophia
Gkletsos, Apostolos
Parga, Maria
Karras, Theodoros
author_facet Kalfas, Dimitrios
Markou, Sophia
Gkletsos, Apostolos
Parga, Maria
Karras, Theodoros
author_sort Kalfas, Dimitrios
collection PubMed
description
format Text
id pubmed-2991820
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29918202010-11-26 The use of amisulpride in schizophrenic patients with resistant symptomatology Kalfas, Dimitrios Markou, Sophia Gkletsos, Apostolos Parga, Maria Karras, Theodoros Ann Gen Psychiatry Meeting Abstract BioMed Central 2010-04-22 /pmc/articles/PMC2991820/ http://dx.doi.org/10.1186/1744-859X-9-S1-S135 Text en Copyright ©2009 Kalfas et al; licensee BioMed Central Ltd.
spellingShingle Meeting Abstract
Kalfas, Dimitrios
Markou, Sophia
Gkletsos, Apostolos
Parga, Maria
Karras, Theodoros
The use of amisulpride in schizophrenic patients with resistant symptomatology
title The use of amisulpride in schizophrenic patients with resistant symptomatology
title_full The use of amisulpride in schizophrenic patients with resistant symptomatology
title_fullStr The use of amisulpride in schizophrenic patients with resistant symptomatology
title_full_unstemmed The use of amisulpride in schizophrenic patients with resistant symptomatology
title_short The use of amisulpride in schizophrenic patients with resistant symptomatology
title_sort use of amisulpride in schizophrenic patients with resistant symptomatology
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991820/
http://dx.doi.org/10.1186/1744-859X-9-S1-S135
work_keys_str_mv AT kalfasdimitrios theuseofamisulprideinschizophrenicpatientswithresistantsymptomatology
AT markousophia theuseofamisulprideinschizophrenicpatientswithresistantsymptomatology
AT gkletsosapostolos theuseofamisulprideinschizophrenicpatientswithresistantsymptomatology
AT pargamaria theuseofamisulprideinschizophrenicpatientswithresistantsymptomatology
AT karrastheodoros theuseofamisulprideinschizophrenicpatientswithresistantsymptomatology
AT kalfasdimitrios useofamisulprideinschizophrenicpatientswithresistantsymptomatology
AT markousophia useofamisulprideinschizophrenicpatientswithresistantsymptomatology
AT gkletsosapostolos useofamisulprideinschizophrenicpatientswithresistantsymptomatology
AT pargamaria useofamisulprideinschizophrenicpatientswithresistantsymptomatology
AT karrastheodoros useofamisulprideinschizophrenicpatientswithresistantsymptomatology